Jade Biosciences, Inc.

NASDAQ:JBIO

Biotechnology

Healthcare
$15.49 -1.25%

-$0.21 today

Market cap
$1.07B
Beta
1.45
P/E (TTM)
-7.4
EPS (TTM)
-$2.24
52W Low $6.67High $28.00

Volume 0.79M

Average 0.83M

JBIO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How JBIO compares with its peers on the latest reported figures

JBIO Competitors Peer median
Gross Margin for JBIO and competitors
Company Period LTM level YoY 3-year change
ACRSAclaris Therapeutics, Inc.LTM Mar 202676.3% +55.8 pp+13.5 pp
JBIOJade Biosciences, Inc.FY2025— ——
VERAVera Therapeutics, Inc.FY2025— ——
TRAXFirst Tracks Biotherapeutics IncFY2025— ——
MLTXMoonLake ImmunotherapeuticsFY2025— ——
CTNMContineum Therapeutics, Inc. Class A Common StockFY2025— ——
KYTXKyverna Therapeutics, Inc.FY2025— ——
ELDNEledon Pharmaceuticals, Inc.FY2025— ——
DWTXDogwood Therapeutics, Inc.FY2025— ——
Peer median (excluding JBIO) 76.3%+55.8 pp+13.5 pp

Competitors are the stored peer set for JBIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue15K68K96K282K0
Gross Profit(15K)(68K)(96K)(282K)0
Gross Margin—————
Research & Development14.99M38.62M64.22M53.19M93.12M
Selling, General & Admin8.02M14.55M17.09M21.13M20.42M
Operating Expenses23.01M53.17M81.31M74.31M113.54M
Depreciation & Amortization15K68K96K282K26K
EBITDA(22.95M)(51.42M)(75.37M)(69.29M)(127.33M)
EBITDA Margin—————
Operating Income(23.02M)(53.24M)(81.41M)(74.6M)(113.54M)
Operating Margin—————
Interest Income65K1.83M5.95M5.04M7.78M
Interest Expense00000
Other Income / Expenses62K1.75M5.94M5.02M(13.81M)
Income Before Tax(22.96M)(51.49M)(75.47M)(69.57M)(127.35M)
Pre-Tax Margin—————
Income Tax Expense3K25K56K55K58K
Net Income(22.96M)(51.51M)(75.52M)(69.63M)(127.41M)
Net Margin—————
EPS (Basic)(32.96)(73.67)(100.38)(85.26)(4.06)
EPS (Diluted)(32.96)(73.67)(100.38)(85.26)(4.06)
Weighted Avg Shares697.44K699.2K752.33K816.63K31.36M
Weighted Avg Shares (Diluted)697.44K699.2K752.33K816.63K31.36M

Jade Biosciences, Inc.

NASDAQ:JBIO

Intrinsic Alpha fair value

Locked

Current Price

$15.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.